APRICUS BIOSCIENCES INC | 2,593 Euro | +0,046 +1,81 % | |
| WKN: A1C4WU ISIN: US03832V1098 Ticker-Symbol: NXEN | Frankfurt | 22.05.13 | 08:00 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 22.05. | Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants | - | Benzinga.com | |
| 22.05. | Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants | 37 | GlobeNewswire | |
| SAN DIEGO, 2013-05-22 22:01 CEST (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today
announced that it intends to offer shares of common stock and warrants... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants | ||||
| 15.05. | APRICUS BIOSCIENCES, INC. - 8-K, Current Report | 3 | SEC Filings | |
| 10.05. | Apricus Biosciences Management Discusses Q1 2013 Results - Earnings Call Transcript | 4 | Seeking Alpha | |
| 10.05. | Apricus Biosciences, Inc.: Apricus Biosciences Provides First Quarter 2013 Corporate Update | 24 | GlobeNewswire | |
| Company to Host Conference Call/Webcast Today at 9:00 AM ET
SAN DIEGO, 2013-05-10 14:30 CEST (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(http://www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Provides First Quarter 2013 Corporate Update | ||||
| 07.05. | Apricus Biosciences, Inc.: Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call | 33 | GlobeNewswire | |
| Conference Call/Webcast to Be Held Friday, May 10, 2013 at 9:00 a.m. ET
SAN DIEGO, Calif., 2013-05-07 20:38 CEST (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call | ||||
| 18.04. | APRICUS BIOSCIENCES, INC. - 8-K, Other Events Financial Statements and Exhibits | 1 | SEC Filings | |
| 04.04. | Apricus Offloads Non-Core Assets | 1 | Zacks | |
| 01.04. | Apricus Biosciences Announces Sale Of Non-Core Assets | 64 | AFX News | |
| WASHINGTON (dpa-AFX) - Apricus Biosciences, Inc. (APRI) on Monday announced
the sale of Totect, a marketed, injectable treatment for anthracycline
extravasation, and NitroMist, an FDA-approved... Mehr lesen zu: Apricus Biosciences Announces Sale Of Non-Core Assets | ||||
| 01.04. | Apricus Biosciences Sells Totect for Bicodex Labs Unit | - | Benzinga.com | |
| 01.04. | Apricus Biosciences, Inc.: Apricus Biosciences Announces Sale of Non-Core Assets | 45 | GlobeNewswire | |
| Company Executes Core Strategy to Focus on Its Vitaros(R) and Femprox(R) Sexual
Health Products
SAN DIEGO, 2013-04-01 22:00 CEST (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Announces Sale of Non-Core Assets | ||||
| 01.04. | Apricus Biosciences: A Transformative Year Ahead | - | Seeking Alpha | |
| 18.03. | Apricus Biosciences Management Discusses 2012 Results - Earnings Call Transcript | 2 | Seeking Alpha | |
| 18.03. | Apricus Biosciences Appoints Richard Pascoe As CEO | 64 | AFX News | |
| WASHINGTON (dpa-AFX) - Apricus Biosciences, Inc. (APRI) said Monday that it
has appoointed Richard Pascoe as Chief Executive Officer, effective March 18. In addition to his role as CEO, Pascoe... Mehr lesen zu: Apricus Biosciences Appoints Richard Pascoe As CEO | ||||
| 18.03. | Apricus Biosciences (APRI) Refocuses Strategy on Vitaros, Femprox; Updates on Outlook | 1 | StreetInsider.com | |
| 18.03. | Apricus Biosciences, Inc.: Apricus Biosciences Provides Corporate Update; Files Annual Report for Quarter and Year Ended December 31, 2012 | 35 | GlobeNewswire | |
| Company to Host Conference Call/Webcast Today at 1:00 PM ET
SAN DIEGO, 2013-03-18 16:15 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(http://www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Provides Corporate Update; Files Annual Report for Quarter and Year Ended December 31, 2012 | ||||
| 18.03. | Apricus Biosciences, Inc.: Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer | 27 | GlobeNewswire | |
| Steve Martin to Resume Role as Chief Financial Officer
SAN DIEGO, 2013-03-18 16:00 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer | ||||
| 14.03. | Apricus Biosciences, Inc.: Apricus Biosciences Announces 2012 Year End Financial Results Conference Call | 23 | GlobeNewswire | |
| Conference Call/Webcast to be Held Monday, March 18, 2013 at 1:00 p.m. ET
SAN DIEGO, 2013-03-14 14:00 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Announces 2012 Year End Financial Results Conference Call | ||||
| 14.03. | Apricus Biosciences, Inc.: Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries | 38 | GlobeNewswire | |
| Company to Focus Resources on Vitaros(R) and Femprox(R)
SAN DIEGO, 2013-03-14 13:53 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries | ||||
| 07.03. | Apricus Biosciences, Inc.: Apricus Biosciences to Present at BIO-Europe Spring 2013 | 17 | GlobeNewswire | |
| SAN DIEGO, 2013-03-07 14:00 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
(www.apricusbio.com) announced today that Edward Cox, Vice President Corporate
Development... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences to Present at BIO-Europe Spring 2013 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| ARENA PHARMACEUTICALS | 6,14 | +0,11 % | Arena Pharmaceuticals - Out To Launch Or Out To Lunch? |
| CURASAN | 2,68 | -2,55 % | curasan AG: Starkes erstes Quartal 2013 |
| STADA ARZNEIMITTEL | 34,10 | -0,09 % | STADA: Gute Zahlen und positive Analystenstimmen beflügeln Kurs |
| REPROS THERAPEUTICS | 11,999 | -0,83 % | Repros Therapeutics Makes a Move: Up 8.4% |
| BIONOVO | 0,001 | 0 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-013 |
